Application no. and date | 07866446.3 (espacenet) (Federated) (European Patent Register), 20071026 | Patent/reg. no. and date | DK/EP 2083837, 20150107 | Publication date | 20090805 | Priority no. and date | FR 0609435, 20061027 | EP pub. no. and date |
EP 2083837 20090805 | Effective date | | Applicant/owner | IPSEN PHARMA S.A.S., 65, Quai Georges Gorse
92100 Boulogne-Billancourt, FR | Applicant ref. no. | P81500863DK00E | Inventor | CHABRIER DE LASSAUNIERE, Pierre-Etienne, 134, quai Louis Blériot
75016 Paris, FR, AUGUET, Michel, 29, rue de la Butte de Rheims
91120 Palaiseau, FR, FAVRE, Christine, 34 rue de Bourguignette
91530 Saint Maurice Montcouronne, FR | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 35/74 (2015.01) , A61P 25/04 (2006.01) , A61P 35/00 (2006.01) | Title | Terapeutisk anvendelse af botulinum neurotoxin til behandling af smerter, der er induceret af mindst ét middel mod kræft | Int. application no. | FR2007001773 | Int. publication no. | WO2008059126 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|